VITAL NSE filing

Vital Chemtech Appoints Internal & Secretarial Auditors; Approves Postal Ballot

The RealCase readLow impact Neutral

Vital Chemtech Limited's Board Meeting on March 24, 2026, appointed M/s. Ravi V. Patel & Co. as Internal Auditor for FY 2025-26. M/s. SCS and Co. LLP were appointed Secretarial Auditors for five years (FY26-FY30). The company also approved a Postal Ballot process and appointed an E-Voting Agency and Scrutinizer.

Why it matters

The appointment of auditors and the initiation of a postal ballot are standard corporate governance procedures and do not represent a significant strategic or financial event for the company.

The market read

The announcement pertains to routine corporate appointments and procedural matters related to a postal ballot, with no immediate financial implications or significant strategic shifts disclosed.

Vital Chemtech Limited announced the outcome of its Board Meeting held on March 24, 2026. The Board approved the appointment of M/s. Ravi V. Patel & Co., Chartered Accountant, as the Internal Auditor for the Financial Year 2025-26, based on the recommendation of the Audit Committee.

Furthermore, M/s. SCS and Co. LLP, Practicing Company Secretaries, have been appointed as the Secretarial Auditor for a term of five consecutive financial years, from FY 2025-2026 to FY 2029-2030, subject to shareholder approval. The company also discussed and approved the draft Postal Ballot Notice, authorizing executive directors and the Company Secretary & Compliance Officer to issue it to members. National Securities Depository Limited (NSDL) was appointed as the E-Voting Agency for the postal ballot process, and M/s. Mittal V. Kothari & Associates was appointed as the Scrutinizer for the same.

The Board meeting, which commenced at 3:00 PM IST and concluded at 3:30 PM IST, also considered other agenda items as decided by the Board.

Filing to action

What to do with a filing like this

Vital Chemtech Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Vital Chemtech Limited. Read the original for the full detail.

View original filing